Kesler Norman & Wride LLC trimmed its position in Intuitive Surgical, Inc. (NASDAQ:ISRG – Free Report) by 47.0% in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 1,069 shares of the medical equipment provider’s stock after selling 949 shares during the quarter. Kesler Norman & Wride LLC’s holdings in Intuitive Surgical were worth $478,000 at the end of the most recent quarter.
Other large investors have also made changes to their positions in the company. Tobam grew its position in Intuitive Surgical by 666.7% during the 2nd quarter. Tobam now owns 46 shares of the medical equipment provider’s stock worth $25,000 after purchasing an additional 40 shares in the last quarter. Kilter Group LLC acquired a new stake in shares of Intuitive Surgical in the second quarter worth $27,000. Princeton Global Asset Management LLC acquired a new stake in shares of Intuitive Surgical in the second quarter worth $30,000. Riggs Asset Managment Co. Inc. grew its holdings in shares of Intuitive Surgical by 84.2% during the second quarter. Riggs Asset Managment Co. Inc. now owns 70 shares of the medical equipment provider’s stock valued at $38,000 after buying an additional 32 shares in the last quarter. Finally, 1248 Management LLC acquired a new position in Intuitive Surgical during the first quarter valued at $41,000. Institutional investors and hedge funds own 83.64% of the company’s stock.
Intuitive Surgical Stock Up 0.2%
NASDAQ ISRG opened at $586.24 on Friday. The stock has a market capitalization of $210.16 billion, a PE ratio of 77.55, a price-to-earnings-growth ratio of 4.77 and a beta of 1.67. Intuitive Surgical, Inc. has a 12-month low of $425.00 and a 12-month high of $616.00. The company has a 50 day moving average price of $565.95 and a two-hundred day moving average price of $511.45.
Analyst Ratings Changes
Several equities analysts have weighed in on ISRG shares. HSBC lifted their target price on Intuitive Surgical from $595.00 to $644.00 and gave the company a “buy” rating in a research note on Thursday, October 23rd. Sanford C. Bernstein reaffirmed an “outperform” rating and set a $740.00 price objective (up from $700.00) on shares of Intuitive Surgical in a research report on Friday. Daiwa Capital Markets upped their price objective on shares of Intuitive Surgical from $510.00 to $550.00 and gave the company an “outperform” rating in a research note on Friday, October 24th. Evercore ISI set a $580.00 target price on shares of Intuitive Surgical in a research report on Monday, January 5th. Finally, Truist Financial boosted their price target on shares of Intuitive Surgical from $620.00 to $650.00 and gave the company a “buy” rating in a report on Thursday, December 18th. Two equities research analysts have rated the stock with a Strong Buy rating, sixteen have issued a Buy rating, eight have assigned a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $622.17.
Read Our Latest Stock Report on Intuitive Surgical
Insider Activity at Intuitive Surgical
In related news, EVP Henry L. Charlton sold 13,731 shares of the firm’s stock in a transaction that occurred on Wednesday, November 12th. The stock was sold at an average price of $580.00, for a total value of $7,963,980.00. Following the transaction, the executive vice president directly owned 3,056 shares of the company’s stock, valued at approximately $1,772,480. This trade represents a 81.80% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. Also, insider Gary S. Guthart sold 28,800 shares of the business’s stock in a transaction that occurred on Friday, October 24th. The stock was sold at an average price of $547.56, for a total value of $15,769,728.00. Following the completion of the sale, the insider owned 27,027 shares of the company’s stock, valued at approximately $14,798,904.12. This trade represents a 51.59% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Over the last quarter, insiders sold 114,007 shares of company stock valued at $63,533,844. Insiders own 0.70% of the company’s stock.
Intuitive Surgical Profile
Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.
In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.
Recommended Stories
- Five stocks we like better than Intuitive Surgical
- Elon Taking SpaceX Public! $100 Pre-IPO Opportunity!
- A U.S. “birthright” claim worth trillions – activated quietly
- Ticker Revealed: Pre-IPO Access to “Next Elon Musk” Company
- First Time Since 2007: All Warnings Active
- How the Rich Retire
Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.
